Tablet placebo for aficamten 5mg tablet, Aficamten clinical trials

A Phase 3, Multi-Center, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

This study is testing a new tablet, Aficamten, for people with a heart condition called non-obstructive hypertrophic cardiomyopathy. It compares Aficamten to a dummy pill to see if it improves how people feel and their exercise ability.